REDSHIFTbio_TM_tag

RedShiftBio Product Launch PEGS 2018

Booth #316

Schedule a meeting with our team

Following the closing of last year’s $11 Million Series C equity financing, RedShiftBio is excited to announce the launch of an IR instrument at PEGS. The instrument is powered by a new sensing technology called Microfluidic Modulation Spectroscopy, allowing you to see change in protein characterization that is not possible today. Participants in last year’s equity financing included Waters Corporation (NYSE:  WAT), the world's leading specialty measurement company in the development and manufacture of innovative analytical solutions, and Technology Venture Partners, a venture capital firm specializing in technology and healthcare. Both Waters and RedShiftBio are hosting many events at PEGS.

Come meet with us during the conference:

3:05PM

TUESDAY

Anders Lund, PhD, Scientific Director, Bioanalytics Characterization Group, BioPharmaceutics Development, Sanofi

Lessons from the Development and Execution of an Automated Purification, Digestion, and Targeted LCMS Analysis (MAM) of Biotherapeutics

3:35pm

TUESDAY

Happy Hour!

RedShiftBio Happy Hour on booth #316. Come and learn about a new technique for measuring Aggregation, Quantitation, Structure, Similarity, and Stability in one single analyzer.

10:20am

WEDNESDAY

Product Launch Presentation

RedShiftBio Product Launch Presentation in the Theatre Area of the main exhibit hall. Hear RedShiftBio CTO, Eugene Ma, showcase the Microfludic Modulation Spectroscopy Analyzer and case studies from a few of our many collaborators.

Poster Sessions

LUCY LIU, PFIZER 

Thermal Denaturation Analysis of Bovine Serum Albumin by Microfluidic Modulation Spectroscopy

LIBO WANG, REDSHIFTBIO & BRENT KENDRICK, ELION LABS, A DIVISION OF KBI BIOPHARMA 

HOS Study for IgG Samples Spiked with Different Amount of BSA by MMS

EUGENE MA, REDSHIFTBIO

Enhanced Protein  Structural Characterization using MMS